Therma Bright (TBRIF)
OTHER OTC:TBRIF
TBRIF Stock Chart & Stats
$0.04
<$0.01(2.88%)
At close: 4:00 PM EST
$0.04
<$0.01(2.88%)
Day’s Range― - ―
52-Week Range$0.03 - $0.19
Previous CloseN/A
Volume100.00
Average Volume (3M)4.36K
Market Cap
$2.72M
Enterprise Value$3.80M
Total Cash (Recent Filing)$36.19K
Total Debt (Recent Filing)$40.00K
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Jul 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding58,002,876
10 Day Avg. Volume395
30 Day Avg. Volume4,359
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.51
Price to Sales (P/S)48.92
P/FCF Ratio-26.80
Enterprise Value/Market Cap1.40
Enterprise Value/Revenue56.40
Enterprise Value/Gross Profit255.09
Enterprise Value/Ebitda-0.97
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Reported DebtVery low reported debt materially reduces near-term leverage risk and interest obligations, giving management breathing room to execute restructuring or commercialization moves. That durable low-leverage profile improves flexibility to raise capital or negotiate terms without heavy debt service pressure.
Gross Margin RecoveryA return to positive gross margins (~22% TTM) signals improving unit economics or cost/pricing discipline. If sustained, this bolsters the path to operating leverage, making incremental revenue more profitable and supporting eventual progress toward sustainable profitability over the medium term.
Operating Cash Flow ImprovementMarked improvement in operating cash outflows shows management tightening spending and improving cash discipline. This reduces immediate financing urgency, extends runway, and indicates operational adjustments that, if continued, could enable the company to stabilize cash flow without permanent structural dilution.
Bears Say
Negative Shareholders' EquityMeaningfully negative equity reflects accumulated losses and a weakened balance sheet, limiting financial flexibility and making new equity raises or credit access more dilutive or costly. Over the medium term, negative equity constrains strategic options and heightens solvency scrutiny from counterparties.
Persistent Cash BurnConsistent negative operating and free cash flow means the business cannot self-fund growth or operations and will require external financing. This structural cash deficit raises dilution and refinancing risk, restricting long-term investment in commercialization or product development.
Volatile, Declining Revenue & Deep LossesA declining, inconsistent top line combined with very large negative net margins signals weak product-market fit or limited commercial traction. Over months, this undermines scale economics, complicates forecasting, and indicates a long runway to profitability absent clear structural revenue recovery.
Therma Bright News
TBRIF FAQ
What was Therma Bright’s price range in the past 12 months?
Therma Bright lowest stock price was $0.03 and its highest was $0.19 in the past 12 months.
What is Therma Bright’s market cap?
Therma Bright’s market cap is $2.72M.
When is Therma Bright’s upcoming earnings report date?
Therma Bright’s upcoming earnings report date is Jul 01, 2026 which is in 82 days.
How were Therma Bright’s earnings last quarter?
Therma Bright released its earnings results on Apr 07, 2026. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
Is Therma Bright overvalued?
According to Wall Street analysts Therma Bright’s price is currently Overvalued.
Does Therma Bright pay dividends?
Therma Bright does not currently pay dividends.
What is Therma Bright’s EPS estimate?
Therma Bright’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Therma Bright have?
Therma Bright has 58,002,876 shares outstanding.
What happened to Therma Bright’s price movement after its last earnings report?
Therma Bright reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.511%.
Which hedge fund is a major shareholder of Therma Bright?
Currently, no hedge funds are holding shares in TBRIF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Therma Bright
Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. It serves consumers and medical professionals. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. Therma Bright Inc. was incorporated in 2001 and is based in Toronto, Canada.
Technical Analysis
Imagin Medical
―
Perimeter Medical Imaging AI
―
Profound Medical
―
Theralase Technologies
―
Aquarius Surgical Technologies
―